Monochronic excimer light (308 nm): An immunohistochemical study of cutaneous T cells and apoptosis-related molecules in psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 4, 2003, Pages 408-413

  Bianchi, Beatrice ^a   Campolmi, P ^a   Mavilia, L ^a   Danesi, A ^a   Rossi, R ^a   Cappugi, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

308 nm UVB; Apoptosis; Bcl 2; Immunosuppression; Ki 67; p53; Psoriasis; T lymphocyte; TUNEL

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGE; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DERMIS; EPIDERMIS; EXCIMER LASER; FEMALE; GENDER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHOSPHATASE TECHNIQUE; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; KERATINOCYTE; LOW LEVEL LASER THERAPY; LYMPHOCYTE DEPLETION; LYMPHOCYTIC INFILTRATION; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PSORIASIS VULGARIS; RADIATION ENERGY; REMISSION; SKIN BIOPSY; SKIN CELL; SKIN DEFECT; SKIN PENETRATION; T LYMPHOCYTE; ULTRAVIOLET B RADIATION; UPREGULATION; WOUND HEALING; COMPARATIVE STUDY; CYTOLOGY; EPIDEMIOLOGY; FOLLOW UP; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PHOTOTHERAPY; PROBABILITY; PROSPECTIVE STUDY; PSORIASIS; RADIATION EXPOSURE; RADIATION RESPONSE; RISK ASSESSMENT; SKIN; TREATMENT OUTCOME; ULTRAVIOLET RADIATION;

ADULT; AGED; APOPTOSIS; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; PSORIASIS; RISK ASSESSMENT; SAMPLING STUDIES; SKIN; T-LYMPHOCYTES; TREATMENT OUTCOME; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY;

EID: 0037592124     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00758.x     Document Type: Article

References (22)

1. Iizuka H, Ishida-Yamamoto A, Honda H. Epidermal remodeling in psoriasis. Br J Dermatol 1996; 135: 433-438.
2. Iizuka H, Honda H, Ishida-Yamamoto A. Epidermal remodeling in psoriasis (II): a quantitative analysis of the epidermal architecture J Invest Dermatol 1997; 109: 806-810.
3. Takahashi H, Manabe A, Ishida-Yamamoto A, Hashimoto Y, Iizuka H. Aberrant expression of apoptosis-related molecules in psoriatic epidermis. J Dermatol Sci 2002; 28: 187-197.
4. Onuma J. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J Dermatol 1994; 21: 223-232.
5. Krueger JG, Wolfe JT, Nabeya RT et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995; 182: 2057-2068.
6. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 1988; 119: 691-696.
7. Guckian M, Jones CD, Vestey JP et al. Immunomodulation at the initiation of phototherapy and photochemotherapy. Photodermatol Photoimmunol Photomed 1995; 11: 163-169.
8. Bonis B, Kemeny L, Dobozy A et al. 308-nm UVB excimer laser for psoriasis. Lancet 1997; 350: 1522.
9. Asawanonda P, Anderson RR, Chang Y, Taylor CR. 308 excimer laser for the treatment of psoriasis: a dose-response study. Arch Dermatol 2000; 136: 619.
10. Kemeny L, Bonis B. 308-nm excimer laser therapy for psoriasis. Arch Dermatol 2001; 137: 95.
11. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359-362.
12. Campolmi P, Mavilia L, Lotti TM et al. 308 nm monochromatic excimer light for the treatment of palmoplantar psoriasis. Int J Immunopathol Pharmacol 2002; 13 (Suppl. 1): 11-13.
13. Cooper KD. Cell-mediated immunosuppressive mechanisms induced by UV radiation. Photochem Photobiol 1996; 63: 400-406.
14. Simon JC, Krutmann J, Elmets CA, Bergstresser PR, Cruz PD Jr. Ultraviolet B-irradiated antigen-presenting cells display altered accessory signaling for T-cell activation: relevance to immune responses initiated in skin. J Invest Dermatol 1992; 98: 66S-69S.
15. Ozawa M, Ferenczi K, Kicuchi T et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999; 189: 711-718.
16. Cappugi P, Mavilia L, Mavilia C et al. 308 nm monochromatic excimer light in psoriasis: clinical evaluation and study of cytokine levels in the skin. Int J Immunopathol Pharmacol 2002; 13 (Suppl. 1): 14-19.
17. Schwartz SM, Bennett MR. Death by any other name. Am J Pathol 1995; 147: 229-234.
18. Cotton J, Spandau DF. Ultraviolet B-radiation dose influences the induction of apoptosis and p53 in human keratinocytes. Radiat Res 1997; 147: 148-155.
19. Yaron I, Yaron R, Oluwole SF, Hardy MA. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents. Cell Immunol 1996; 168: 258-266.
20. Myashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1994; 54: 3131-3135.
21. Wrone-Smith T, Hohnson T, Nelson B et al. Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes. Am J Pathol 1995; 146: 1079-1088.
22. Hockenbery DM, Zutter M, Hickey W et al. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-6965.